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Abstract: This study investigates the prevalence and demographic characteristics of 
hypersexuality in Parkinson’s disease (PD). Impulse control disorders in PD patients have been 
associated with dopamine agonist therapy. Moreover, hypersexuality and pathological gambling 
have been associated with males, while females may be inherently thought to be more likely 
to participate in compulsive shopping and binge-eating behaviors. In this study, a screening 
mail-in survey was sent to all PD patients at a single Movement Disorders Center. One hundred 
forty one of 400 (35.3%) research packets were returned completed. Fifteen of 141 patients met 
initial screening criteria for hypersexual behavior. After detailed interview, only 6/141 (4.3%) 
of PD patients met criteria for pathologic hypersexual behavior. These behaviors included: 
compulsive masturbation, prostitution, and paraphilias. Patients with a younger age of PD 
onset were more likely to exhibit hypersexual behavior. Unlike previous report, no signiﬁ  cant 
association was found between hypersexuality and gender or dopamine agonist use. Rather, this 
study suggests that physicians should be vigilant for hypersexual behavior in all PD patients, 
regardless of gender and PD medication regimen. Ultimately, given the innate sensitivity of 
the topic and survey limitations, it is very likely that hypersexual behavior in our cohort, as it 
is in the general PD population, has been under-reported.
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Introduction
Impulse control disorders are increasingly reported in Parkinson’s disease (PD). 
Examples of these iatrogenic behaviors seen in PD include: binge eating, excessive 
spending, compulsive shopping, pathological gambling, and hypersexuality.1 Hyper-
sexuality in particular is a psychiatric issue that patients are often reluctant to discuss. 
Voon and colleagues found the lifetime prevalence of pathologic hypersexuality in PD 
to be 2.4%.1 Hypersexual behavior typically entails an increase in premorbid sexual 
activities as well as an increase in the variety of sexual behaviors.2 While no direct 
cause has been identiﬁ  ed, Voon and colleagues found hypersexuality to be signiﬁ  cantly 
associated with male sex and an earlier age of PD onset.1 Treatment with dopamine 
agonist therapy and a history of impulse control disorders has also been proposed as 
possible risk factors.3
This study investigates prevalence and demographic characteristics of hypersexual 
behavior in PD patients residing in north central Florida, USA.
Methods
The study was approved by the Institutional Review Board of the University of Florida. 
Four hundred packets were mailed to all patients diagnosed with idiopathic PD enrolled 
in the Movement Disorders Center of the University of Florida. The diagnosis was made International Journal of General Medicine 2009:2 58
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by a fellowship trained movement disorders specialists and was 
based on fulﬁ  lling strict United Kingdom Brain Bank Criteria.4 
As approved by the University of Florida Institutional Review 
Board, in the survey phase of this study, the subject’s response 
to the questionnaire was considered an “implied consent”. 
In addition, all patients signed a separate informed consent 
to allow us to contact them, if needed, and to have their data 
analyzed. Information on demographics, health history, current 
therapies, and hypersexual behavior was obtained in addition to 
the Neuropsychological Inventory (NPI) and Beck’s Depres-
sion Inventory (BDI).
Patients were asked directly if they participated in hyper-
sexual behavior on the hypersexual behavior questionnaire 
(see Table 1). As part of the mail-in survey, the patients were 
asked if they would like to be further contacted in regard 
to this research survey. Only those patients who consented 
were subsequently interviewed for conﬁ  rmation and clas-
siﬁ  cation to determine if they met the diagnostic criteria for 
subsybdromal or pathological hypersexuality as outlined by 
Voon and colleagues (see Table 2).1 The patient’s signiﬁ  cant 
other participated in the interview if the patient consented 
and was available at the time.
Continuous demographic variables (eg, age of onset, PD 
duration, NPI, BDI) were analyzed using unpaired t tests. 
Categorical demographic variables (eg, gender, handedness, 
marital status, times married, side of PD onset, smoking his-
tory, psychiatric history, family psychiatric history, dopamine 
agonist therapy, and levodopa therapy) were analyzed using 
Fisher’s exact tests and Chi-squared tests. All statistical 
analyses were performed using GraphPad Prism (GraphPad 
Software, Inc., La Jolla, CA, USA) software.
Results
One hundred forty-one from 400 (35.3%) patients returned 
completed research packets. This sample had a mean age of 
68.0 years (± 10.2 yrs) and an average PD duration of 6.7 years 
(± 5.9 yrs). Fifteen of 141 respondents self-identiﬁ  ed as pos-
sessing hypersexual behavior. Only six of 15 patients met 
criteria for pathological hypersexuality (n = 5) or subsyndro-
mal hypersexuality (n = 1). Whenever there was a question on 
the veracity of patient reports or reliability of their testimony, 
the subject’s partner participated in the interviews, and in all 
cases these patients qualiﬁ  ed as exhibiting pathological hyper-
sexual behavior. The prevalence therefore of hypersexuality 
in our cohort was 4.3% (6/141). In these six patients, the 
most common hypersexual behavior reported was increased 
pornography interest (magazine, video, or Internet) (three of 
the six patients), and compulsive masturbation (two patients). 
Individually, patients also reported novel interests in a wide 
range of behaviors including sexual toys, sadomasochism, 
prostitution, and cross-dressing. The average age of PD onset 
was signiﬁ  cantly lower in the hypersexual group (50.2 yrs ± 3.0) 
compared to the nonhypersexual group (61.5 yrs ± 1.0) 
(t(124) = 2.437; p  0.05). No signiﬁ  cant association was 
found between hypersexual behavior and gender, handedness, 
marital status, times married, side of PD onset, psychiatric 
history, family psychiatric history, dopamine agonist therapy, 
levodopa therapy, PD duration, NPI or BDI score. Interestingly, 
this sample showed a signiﬁ  cant association between a history 
of smoking and not developing hypersexual behavior (Fisher’s 
exact test p  0.05).
Discussion
Given the innate sensitivity of the topic, it is very likely that 
hypersexual behavior is under-reported. Despite the limita-
tions (and probable underestimation) of a mail-in survey, 
the prevalence of hypersexuality in our PD cohort (4.3%) 
was slightly higher than the 2.4% reported by Voon and 
colleagues.1 Patients with a younger age of PD onset were 
more likely to exhibit hypersexual behavior.
Previously, hypersexuality was associated with males but 
not females.1 Our current study failed to substantiate this ﬁ  nd-
ing. This highlights the possibility of hypersexual behavior 
in female patients that may be missed due to the inherently 
small sample size of hypersexual patients.
Although the association between younger age of onset 
and hypersexual behavior might be thought to be due to a 
greater use of dopamine agonist therapy in these patients, no 
signiﬁ  cant relationship was found between dopamine agonist 
therapy and hypersexual behavior in this sample. Klos and col-
leagues found that hypersexual behavior typically began after 
eight months of dopamine therapy and then resolved after dis-
continuing dopamine agonist therapy.5 It should be noted that 
a few patients in our study did mention a similar experience. 
Shaw and colleagues proposed dopamine therapy in general 
may cause hypersexuality both directly, by increasing libido 
and arousal, and indirectly by interacting with reward-center 
neural substrates.2 This is in line with the Voon and colleagues 
ﬁ  nding that a higher total levodopa dose equivalent, but not 
dopamine agonist dose, was associated with hypersexual-
ity.1 Intuitively, it seems very likely that manipulation of the 
dopamine system would result in changes in reward-seeking 
behavior. Additional compulsive behaviors coincide with 
hypersexuality in up to 60% of hypersexual PD patients.5
Given that only a relatively small percentage of PD 
patients exhibit hypersexuality or any type of impulse International Journal of General Medicine 2009:2 59
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Table 1 Questionnaire: Hypersexual behavior in Parkinson’s disease
The following questions address hypersexual behaviors. Please answer the following questions honestly and to the best of your ability. (Please circle 
your answer)
1. Yes or No Do you participate in hypersexual behaviors? If yes, please answer all questions. If no, please proceed to next questionnaire.
2. Yes or No Do you engage in compulsive sexual behavior?
3. Yes or No Do you exhibit sexual behavior more than you should?
4. How often do you engage in hypersexual behavior? Circle one:
  Quarterly Monthly Weekly Daily
5. Yes or No Did you have hypersexual behavior before your diagnosis?
6. Yes or No Has your hypersexual behavior increased since your diagnosis?
7. Yes or No Have you noticed an increase in hypersexual behavior since a medication adjustment? If yes, please describe:
8. What forms of hypersexual behavior do you participate in? You may mark more than one answer.
  Compulsive  masturbation
  Prostitution
  Porn  mags
  Extramarital  affairs
  Porn  videos
  Internet  porn
    Internet sex chat rooms
  Heterosexual  promiscuity
  Homosexual  promiscuity
    Telephone sex dependence
    Use of sexual accessories/or toys
  Voyeurism
  Other  (please  describe)
  9. Yes or No Is there a history of hypersexual behavior in your family?
10. Yes or No Do you have an increased urge to engage in hypersexual behavior?
11. Yes or No Does your hypersexual behavior bother you or make you feel guilty?
12. Yes or No Has anyone ever said anything to you about your hypersexual behavior?
13. Yes or No Do you ﬁ  nd yourself exhibiting hypersexual behavior predominantly either “On” or “Off” medication? If yes, please specify:
  On Off On  and  Off
14. Yes or No Do you constantly have sexual thoughts?
15.  How do you feel when you are exhibiting hypersexual behavior? You may select more than one answer.
  Nervous
  Depressed
Anxious
Invincible
Excited
Guilty
Happy Relaxed Sad Worried 
  Other:
16.  How do you feel when you are not exhibiting hypersexual behavior? You may select more than one answer.
  Nervous
  Depressed
Anxious
Invincible
Excited
Guilty
Happy Relaxed Sad Worried
  Other:
17.  How do you feel after the hypersexual behavior has been exhibited? You may select more than one answer.
  Nervous
  Depressed
Anxious
Invincible
Excited
Guilty
Happy Relaxed Sad Worried 
  Other:
18. Yes or No Have you ever borrowed money or sold anything to ﬁ  nance your hypersexual behavior?International Journal of General Medicine 2009:2 60
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control disorder, it seems likely that susceptibility may 
be due to underlying heritable temperamental traits such 
as novelty-seeking.6 Moreover, Pontone and colleagues 
found an association between impulse control disorders 
and depressed mood, disinhibition, irritability, and appe-
tite disturbance.7 Table 3 shows demographic data from 
our current hypersexual population. While not statistically 
signiﬁ  cant, ﬁ  ve out of six patients had either a personal or 
family history of previous psychiatric disorders. Notably, 
none of the patients had a history of hypersexual behavior 
prior to PD onset. Also, there appears to be a trend of 
elevated depression scores, as measured by the BDI, in a 
majority of these patients.
It should be noted that this study relied on a population of 
patients all from a single Movement Disorders Center. There-
fore it is possible that it does not represent the general PD 
population. Similar studies in subsequent populations would 
help to eliminate the possibility of a population bias.
Also, due to survey limitations, as well as possible 
patient cognitive decline, it is possible that not all patients 
understood the survey questions as intended. Since we relied 
on initial self-identiﬁ  cation of hypersexual behavior before 
interviewing, it is quite possible that not all patients were able 
or willing to make this identiﬁ  cation. In the future, studies 
with a larger hypersexual sample size might serve to verify 
signiﬁ  cant demographic variables.
Our study suggests that hypersexuality may be more 
prevalent than currently realized. It conﬁ  rms previous reports 
that it occurs more commonly in the younger PD age group. 
Clinicians should be aware of possible hypersexual behavior 
in both sexes, regardless of dopamine agonist therapy, and be 
prepared to provide information and support to their patients 
and their patients’ caregivers.
Table 2 Proposed operational diagnostic criteria for pathologic 
hypersexuality1
A.  The sexual thoughts or behaviors are excessive or an atypical change 
from baseline marked by one or more of the following:
  1.  Maladaptive preoccupation with sexual thoughts.
 2.   Inappropriately or excessively requesting sex from spouse 
or partner.
 3. Habitual  promiscuity.
 4. Compulsive  masturbation.
  5.  Telephone sex lines or pornography.
 6. Paraphilias.
B. The behavior must have persisted for at least one month.
C. The behavior causes at least one or more of the following:
 1. Marked  distress.
 2.   Attempts to control thoughts or behavior unsuccessful or result 
in marked anxiety or distress.
  3.  Are time consuming.
 4. Interfere  signiﬁ  cantly with social or occupational functioning.
D.  The behavior does not occur exclusively during periods of hypomania 
or mania.
E. If all criteria except C are fulﬁ  lled, the disorder is subsyndromal.
Table 3 Demographic data of hypersexual behavior patient sample
Patients diagnosed with hypersexual behavior
Patient 1 2 3 4 5 Subsyndromal
Current age 54 64 59 74 52 60
Gender Male Male Male Female Male Male
Marital status Married Married Married Married Married Married
Times married 1 1 1 4 1 1
PD duration (years) 19 1 25 9 4
Age of onset 45 58 49 43 56
Handedness Right Right Left Right Right Right
PD side started Right Right Both Right Right Left
Alcohol consumption Never Never Occasionally Never Never Never
Levodopa Yes Yes No Yes Yes No
Dopamine agonist No Yes Yes Yes Yes Yes
Past psych history Yes No No Yes Yes Yes
Past family psych history Yes Yes No Yes No Yes
Past hypersexual 
behavior
No No No No No No
NPI 10 10 3 0 8
BDI 18 17 11 1 17
Abbreviations: BDI, Beck’s Depression Inventory; NPI, Neuropsychological Inventory; PD, Parkinson’s disease.International Journal of General Medicine 2009:2 61
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